m law group advises QureInvest AG in series A financing round of CT Atlantic AG
MLawGroup advises QureInvest AG in a series A financing
of CT Atlantic AG in the amount of CHF 10m.
The proceeds of the financing round will be used to advance CT Atlantic's research and technology programs in order to eventually enter into a strategic alliance with a major pharmaceutical company active in the field of immunotherapy.
QureInvest is a company investing equity in biotech and life science businesses with a focus on seed and early stage companies. CT Atlantic AG is a Swiss biotechnology company focused on the identification and development of human-derived antibodies for the treatment of cancer. The company's corporate headquarters and research facility are located in Zurich.
Counsel to QureInvest AG:
m law group: Dr. Hubert Besner